NIH

President Obama’s FY 2014 Budget Proposal - Analysis Related To Administration Funding And Policy Priorities

by Patton Boggs LLP on 4/15/2013

INTRODUCTION - On April 10th, President Obama submitted his FY 2014 Budget Proposal to Congress. In the normal course of events, the President would have unveiled his spending plan in early February as required by law....more

Healthcare Provisions In The American Taxpayer Relief Act - The Good, The Bad And The Ugly

by Susan Feigin Harris | BakerHostetler on 1/15/2013

In late night action on December 31, 2012, the American Taxpayer Relief Act of 2012 (ATRA) was passed by the Senate and finalized days later by Congress and the President with a set of tax and spending policy provisions...more

Supreme Court Will Not Hear Stem Cell Funding Petition

by Joseph P. Hammang, Alexander Hecht, Robert C. Skinner | Mintz Levin on 1/15/2013

..The on again, off again nature of federal funding for human embryonic stem cell (hESC) research has created a great deal of uncertainty for academic scientists, major research medical centers, venture capital investors,...more

Supreme Court Denies Certiorari in Stem Cell Funding Case

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 1/8/2013

In an order issued earlier today, the Supreme Court denied certiorari in Sherley v. Sebelius, ending the efforts by two adult stem cell researchers to prevent the National Institutes of Health (NIH) from funding research...more

Federal Stem Cell Funding Approved by Appellate Court

by Foley & Lardner LLP on 8/28/2012

Good news for patients and stem cell researchers alike. On August 24th, the United States Courts of Appeals for the District of Columbia Circuit affirmed the District of Columbia court decision granting the government’s...more

Navigating the Evolving Regulation and Commercialization of Stem Cell Research

by McDermott Will & Emery on 3/22/2012

Interested parties that can successfully navigate the evolving regulation of stem cell research stand to gain significant scientific and commercial advantage. Given that in the fall of 2011 the Court of Justice of the...more

MultiStem: A Promising New Stem Cell Therapy Still Under Investigation

by Demas Law Group on 1/24/2011

Every new promising approach to treating spinal cord injuries (SCIs) is critical to the United States since close to 1,200,000 Americans are currently battling some form of this disability. Furthermore, another 12,000 to...more

NIH Approves First Human Embryonic Stem Cell Lines Under New NIH Guidelines

by Ice Miller LLP on 12/4/2009

The National Institutes of Health, a component of the U.S. Department of Health and Human Services, approved the first human embryonic stem cell lines under the new NIH Guidelines for Human Stem Cell Research. ...more

Commercializing Stem Cell-Based Therapies: Meeting NIH and FDA Requirements by Kalah Auchincloss

by Foley Hoag LLP on 9/9/2009

In March, President Obama signed an executive order lifting the Bush Administration restrictions on federal funding for human embryonic stem cell (HES) research. The possibility of new federal funding opportunities, in...more

NIH Releases Guidelines for Federal Funding of Human Embryonic Stem Cell Research

by Foley Hoag LLP on 5/12/2009

According to the National Institutes of Health (“NIH”), “studies of human embryonic stem cells may yield information about the complex events that occur during human development… and could provide information about how...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters